Kitamura S, Nakatani K, Sugihara K, Ohta S
Institute of Pharmaceutical Science, Hiroshima University School of Medicine, Japan.
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999 Mar;122(3):331-6. doi: 10.1016/s0742-8413(98)10134-2.
Converting activity of methotrexate (MTX) to 7-hydroxymethotrexate (7-OH-MTX) was examined using eight strains of rats. Marked variability of the activity was found in liver cytosols from the rats. The highest activity was observed with Sea:SD rats, followed by LEW/Sea and Jcl:Wistar rats. The lowest activity was observed with WKA/Sea rats. The difference in the activity between Sea:SD and WKA/Sea strains was 104-fold. The variation was correlated to the strain difference of benzaldehyde oxidase activity in the rats. The cytosolic 7-hydroxylase activities in other tissues of Sea:SD rats were much higher than those of WKA/Sea, similarly to the case in liver. The liver microsomes of Sea:SD rats exhibited no 7-hydroxylase activity toward MTX even in the presence of NADPH. The cytosolic 7-hydroxylating activity of the livers of Sea:SD rats was inhibited by menadione, beta-estradiol, chlorpromazine and disulfiram, inhibitors of aldehyde oxidase, but not oxypurinol, an inhibitor of xanthine oxidase. The purified aldehyde oxidase from the livers of Sea:SD rats exhibited a significant 7-hydroxylating activity toward MTX. However, xanthine oxidase had no ability to hydroxylate MTX. These facts suggest that MTX hydroxylating activity in rats is predominantly due to aldehyde oxidase, and the strain differences are due to the variations of the flavoenzyme level.
使用八只大鼠研究了甲氨蝶呤(MTX)转化为7-羟基甲氨蝶呤(7-OH-MTX)的活性。在大鼠肝脏胞质溶胶中发现了活性的显著差异。在Sea:SD大鼠中观察到最高活性,其次是LEW/Sea和Jcl:Wistar大鼠。在WKA/Sea大鼠中观察到最低活性。Sea:SD和WKA/Sea品系之间的活性差异为104倍。这种差异与大鼠中苯甲醛氧化酶活性的品系差异相关。与肝脏情况类似,Sea:SD大鼠其他组织中的胞质7-羟化酶活性远高于WKA/Sea大鼠。即使存在NADPH,Sea:SD大鼠的肝脏微粒体对MTX也没有7-羟化酶活性。Sea:SD大鼠肝脏的胞质7-羟化活性受到甲萘醌、β-雌二醇、氯丙嗪和双硫仑(醛氧化酶抑制剂)的抑制,但不受黄嘌呤氧化酶抑制剂氧嘌呤醇的抑制。从Sea:SD大鼠肝脏中纯化的醛氧化酶对MTX表现出显著的7-羟化活性。然而,黄嘌呤氧化酶没有使MTX羟化的能力。这些事实表明,大鼠中的MTX羟化活性主要归因于醛氧化酶,品系差异归因于黄素酶水平的变化。